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Lymphoepithelioma-like Carcinoma of the Urinary Bladder
A 78-yr-old woman presented with gross hematuria for 2 weeks. On cystoscopy, a frond-
like mass was observed at the bladder trigone. Transurethral resection of bladder tumor was 
performed for the mass. Histopathological findings showed that 90% of lesions were 
lymphoepithelioma-like carcinoma (LELCA) and a few lesions were non-invasive transitional 
cell carcinoma. On microscopy, syncytial growth pattern and indistinct cytoplasmic borders 
were observed with the severe infiltration of lymphoid cells. The case was followed-up for 
8 months without recurrence. This is the first report of a LELCA case in Korea.
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CASE REPORT
Oncology & Hematology
INTRODUCTION
Lymphoepithelioma is a term used to designate an undifferen-
tiated malignant epithelial tumor of the nasopharynx that is his-
tologically distinctive because of a markedly prominent lym-
phoid infiltrate (1).
  Carcinomas with similar histological features arising outside 
the nasopharynx are called lymphoepithelioma-like carcinoma 
(LELCA). LELCA occurs in organs such as salivary glands, the 
uterine cervix, the thymus, the lung, the skin, the stomach, the 
bladder, the prostate, and the breast (2).
   It is very rare that LELCA occurs in the urinary system, there 
is one case where it occurred in the renal pelvis, and one case 
where it occurred in the ureter and the kidney simultaneously, 
but has not been reported so far in urinary bladder in Korea. 
The author et al. have lately experienced LELCA that occurred 
in the urinary bladder, and thus have reported the case along 
with philological considerations.
 
CASE REPORT
A 78-yr-old woman presented with gross hematuria for 2 weeks 
on November 23, 2009. There was no history of urologic prob-
lems. The patient was a non-smoker and had not been exposed 
to carcinogen.  Physical examination and vital sign were normal.
  At the time when the patient was admitted to this hospital, 
numerous RBC were observed on urinalysis. There were no no-
table findings on blood test and chest radiography. On cystos-
copy, a frond-like mass was observed at the bladder trigone, 
which measured about 1 cm (Fig. 1). Since hematuria contin-
ued, Foley catheterization was performed.
  On computerized tomography (CT) of the abdomen and pel-
vis, the findings of enhancement and a small-sized mass were 
observed on the inner surface between posterior walls in the 
bladder trigone. The findings of perivesical infiltration and lymph 
node metastasis were not observed. 
  On the authority of above findings, the authors suspected the 
case to be carcinoma in situ of the urinary bladder or transition-
al cell carcinoma, and thus transurethral resection of bladder 
tumor (TURBT) was performed.
  On histopathological examination, it was found that 90% of 
lesions were LELCA and a few lesions were non-invasive transi-
tional cell carcinoma.
  On microscopy, syncytial growth pattern and indistinct cyto-
plasmic borders were observed with the severe infiltration of 
lymphoid cells. The findings of necrosis and mitosis were ob-
served in many regions. It was found that tumor cells invaded 
the whole lamina propria. Non-invasive transitional cell carci-
noma was concomitant fractionally (Fig. 2).
  On immunohistochemical staining, tumor cells were positive 
for cytokeratin 7 but were negative for cytokeratin 20 (Fig. 3). The 
infiltrated lymphocytes were composed of abundant CD3 posi-
tive T cells and CD20 positive B cells. For leukocyte common 
antigen (LCA), lymphoid cells were positive but tumor cells were 
negative (Fig. 4). In situ hybridization for Epstein-Barr virus was 
negative.Yun HK, et al.  •  Lymphoepithelioma-like Carcinoma of the Urinary Bladder
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  The patient has been without recurrence and metastasis for 3 
months after the operation, and currently is on a follow-up.
DISCUSSION 
LELCA of the urinary bladder is rare. LELCA of the urinary blad-
der, first reported by Zuckerberg et al. (3) in 1991, is uncommon 
with a reported incidence between 0.4 and 1.3% of all bladder 
carcinoma (4).
  In the urinary tract, they typically arise in the urinary bladder, 
although isolated cases have been reported in the renal pelvis, 
ureter, and urethra (5, 6).
  As suggested by Amin et al. (7), LELCA was categorized as 
pure (100%), predominantly (more than 50%), or focal (less than 
50%).
  If other classification is applied, LELCA was classified as pure 
when 100% of the tumor showed lymphoepithelioma-like car-
cinoma pattern, and mixed when associated with usual infiltrat-
ing urothelial carcinoma, adenocarcinoma, or squamous carci-
noma (2).  
  It has been suggested that pure/predominant LELCA responds 
to chemotherapy and may best be treated with bladder preser-
vation therapy (1, 13). According to previous reports, pure and 
predominant LELCA is more favorable than focal LELCA in prog-
nosis (2, 3, 7).
  This case was the predominant type that LELCA accounted 
for over 90% of lesions and was fractionally accompanied with 
non-invasive transitional cell carcinoma. The differential diag-
nosis is usually malignant lymphoma, invasive transitional cell 
carcinoma, squamous cell carcinoma and small cell carcinoma. 
It is particularly important to distinguish from malignant lym-
phoma. Amin et al. (5) note that it is imperative to distinguish 
between LELCA and malignant lymphoma, as primary bladder 
lymphoma is extremely rare. Therefore, immunochemical stain-
ing, such as LCA and keratin, may be used for differentiation.
  Siegelbaum et al. (8) maintained that immunochemical stain-
ing techniques were helpful to distinguish bladder lymphoma 
from undifferentiated carcinoma.
  Cystoscopic finding or CT finding is not helpful to distinguish 
LELCA from bladder carcinoma. It is possible to differentiate 
bladder carcinoma from LELCA by microscopic finding. Pooly 
differentiated transitional cell carcinoma (TCC) with a lymphoid 
linfiltrate should be distinguishable from LELCA in that the latter  Fig. 1. Frond-like mass with hemorrhage is detected in bladder.
A B
Fig. 2. Mircoscopic finding. (A) Lymphoepithelioma-like carcinoma, syncytial pattern with prominent lymphocytic infiltrate. (B) Non-invasive transitional cell carcinoma with 
lymphoepithelioma-like carcinoma.Yun HK, et al.  •  Lymphoepithelioma-like Carcinoma of the Urinary Bladder
1674   http://jkms.org DOI: 10.3346/jkms.2010.25.11.1672
A B
Fig. 3. Cytokerain staining. (A) Immunochemical staining with antibodies against cytokeratin 7 is positive. (B) Negative immunochemical staining with antibodies against cyto-
keratin 20.
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Fig. 4. Immunochemical staining. (A) Positive staining with antibodies against CD3 
shows abundant T-cells. (B) Positive staining with antibodies against CD20 shows 
abundant B-cells. (C) Leukocyte common antigen (LCA) stains lymphocytes (left). Non-
invasive transitional cell carcinoma is negative for LCA (right).
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is characterizied by syncytia of tumor cell, vesicular nuclei and 
prominent nuclei (7).
  The microscopic findings of LELCA are characterized by the 
indistinct cytoplasmic border and the syncytial growth pattern 
with the prominent lymphocytic infiltrate. It is important to check 
cytokeratin in tumor cells on immunochemical staining, in or-
der to ascertain that cells are originated from epithelial cells (1).
  The principal symptoms of LELCA were mostly gross hema-
turia, solitary mass, and tumors measured 1 to 5 cm (10, 12). The 
Epstein-Barr virus is regarded as one of factors of the LELCA that 
occurred in the thymus gland (9). However, it has not been elu-
cidated that LELCA of the urinary system is related with EBV (10), 
Gulley et al. (11) reported that EBV, detected from nasophayne-
al carcinoma, was not detected in 9 out of 11 cases of LELCA. 
Also in 9 cases of LELCA reported by Holmang et al. (12), EBV 
was not detected. Likewise, EBV was not detected in this case. 
For LELCA treatment, surgical therapy and chemotherapy can 
be applied.
  In the case of small tumors that measure 5 cm and less, TURBT 
is applied, but in the case of big or invasive tumors, radical cys-
tectomy may be applied. As nasopharyngeal lymphoepithelio-
ma is well reacted to chemotherapy, methotrexate, vinblastine, 
doxorubicin and cisplatin may be applied to chemotherapy (7). 
Dinney et al. (13) reported that primary chemotherapy was per-
formed on 3 patients with muscle invasive lymphoepithelioma 
of the bladder and as a result their bladder functions were sal-
vaged.
  It is presumed that bladder lymphoepithelioma may be well 
reacted to radiotherapy, like nasopharyngeal lymphoepithelio-
ma (14). Holmang et al. (12) applied radiotherapy to 4 patients, 
but could not evaluate whether the patients got cured success-
fully. However, the guideline on LELCA treatment has not been 
established yet.
  LELCA is a rare tumor, and it is important to differentiate it 
from other tumors. In addition, it is necessary to establish the 
definitive standard of its treatment.
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